U.K. trade & investment chief in India on biotech tour

SINGAPORE--The head of the U.K.'s Trade & Investment Ministry has begun a three-day visit to India to focus on biotech and health issues, beginning with the Bangalore India Bio, the nation's major biotech conference.

The stated purpose of Dominic Jermey's first visit to India since taking the post of Trade and Investments CEO last year is to encourage stronger links between U.K. and India businesses.

Dominic Jermey

At the same time, a large delegation of some of what were described as the U.K.'s top biotech and health companies plan to visit. They are involved in oncology, drug discovery, formulations, molecular diagnostics and medical devices, as well as firms dealing with regulatory compliance and intellectual property issues.

A meeting is planned between the delegation and Jermey during his visit that also includes stops in Mumbai and New Delhi, where he plans to meet with key government and business representatives on healthcare and other issues.

- here's the announcement

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.